An SGK1 inhibitor (IC50s = 62 and 103 nM for SGK1 and SGK2, respectively) that demonstrates greater than 30-fold selectivity for SGK1 over Akt and other related kinases; inhibits the androgen-stimulated growth of human prostate carcinoma LNCaP cells (IC50 ~ 1 μM)